{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Familial pulmonary fibrosis",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_bleomycin",
          "name": "Bleomycin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_busulfan",
          "name": "Busulfan"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_nitrofurantoin",
          "name": "Nitrofurantoin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_amiodarone",
          "name": "Amiodarone"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_pirfenidone",
          "name": "Pirfenidone"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_doxorubicin",
          "name": "Doxorubicin"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_gabapentin",
          "name": "Gabapentin"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_radiation_therapy",
          "name": "Radiation therapy"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.07,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.85
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Bleomycin and pulmonary fibrosis",
              "pro": [
                "H1"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Bleomycin 可能加重肺纤维化，且安全性存疑"
          ],
          "safety_risk": [
            "Bleomycin 在肺纤维化患者中有明显风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "对Bleomycin是否确实加重肺纤维化的证据需进一步讨论"
        ]
      },
      {
        "hypothesis_id": "H2",
        "score": 0.07,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.85
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Busulfan and pulmonary fibrosis",
              "pro": [
                "H2"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Busulfan 可能导致肺部毒性，与肺纤维化风险关联"
          ],
          "safety_risk": [
            "临床使用中有明显肺毒性风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "需要进一步探讨Busulfan与肺纤维化的具体机制"
        ]
      },
      {
        "hypothesis_id": "H3",
        "score": 0.12,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.75,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Nitrofurantoin and pulmonary complications",
              "pro": [
                "H3"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Nitrofurantoin 关联肺部并发症，但证据较弱"
          ],
          "safety_risk": [
            "对Nitrofurantoin的肺部毒性数据需要进一步检验"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "缺乏直接针对肺纤维化的进一步研究支持"
        ]
      },
      {
        "hypothesis_id": "H4",
        "score": 0.07,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.8
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Amiodarone and pulmonary damage",
              "pro": [
                "H4"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Amiodarone 可引起肺部损害，与已知副作用相符"
          ],
          "safety_risk": [
            "安全性风险需要考虑"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "安全性机制的验证需进一步深入研究"
        ]
      },
      {
        "hypothesis_id": "H5",
        "score": 0.07,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.75,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Methotrexate and lung fibrosis risk",
              "pro": [
                "H5"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Methotrexate 与肺纤维化风险关联，证据相对一致"
          ],
          "safety_risk": [
            "Methotrexate的安全性需要进一步讨论"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "相关证据未能完全解决潜在风险"
        ]
      },
      {
        "hypothesis_id": "H6",
        "score": 0.03,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.7
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Cyclophosphamide and lung side effects",
              "pro": [
                "H6"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Cyclophosphamide 已知可导致肺部副作用，但不如其他药物明确"
          ],
          "safety_risk": [
            "对其副作用的讨论较少"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "对Cyclophosphamide的安全风险缺乏证据"
        ]
      },
      {
        "hypothesis_id": "H7",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.8,
          "indication_plausibility": 0.9,
          "safety_risk": 0.1,
          "graph_bonus": 0.3,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Nintedanib 被批准用于特发性肺纤维化，具有效果"
          ],
          "safety_risk": [
            "相较其他药物，其安全性较高"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.8,
          "indication_plausibility": 0.9,
          "safety_risk": 0.1,
          "graph_bonus": 0.3,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Pirfenidone 被批准用于特发性肺纤维化，效果明确"
          ],
          "safety_risk": [
            "与其他药物相比，相对安全"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.12,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.35
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.65,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Etoposide and lung toxicity",
              "pro": [
                "H9"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Etoposide 引起肺毒性，但缺乏直接证据支持"
          ],
          "safety_risk": [
            "相较其他药物，数据较少"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "Etoposide 的肺纤维化关联性不明确"
        ]
      },
      {
        "hypothesis_id": "H10",
        "score": 0.04,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.35
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.6,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Doxorubicin and lung fibrosis risk",
              "pro": [
                "H10"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Doxorubicin 与肺纤维化风险有关，但证据链弱"
          ],
          "safety_risk": [
            "安全性需要进一步讨论"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "证据不足，影响不明确"
        ]
      },
      {
        "hypothesis_id": "H11",
        "score": 0.04,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.35
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Gabapentin and pulmonary complications",
              "pro": [
                "H11"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Gabapentin 与肺纤维化相关性低"
          ],
          "safety_risk": [
            "肺纤维化的影响尚不明确"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "缺乏关键证据"
        ]
      },
      {
        "hypothesis_id": "H12",
        "score": 0.04,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.1,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.7
        },
        "graph_signals": {
          "support_weight": 0.0,
          "contradiction_weight": 0.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Radiation therapy and pulmonary issues",
              "pro": [
                "H12"
              ],
              "con": [
                "H7",
                "H8"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "放疗可引起肺部问题，已知风险"
          ],
          "safety_risk": [
            "影响机制尚待研究"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "放疗对肺纤维化的影响尚不明"
        ]
      }
    ],
    "ranking": [
      "H7",
      "H8",
      "H3",
      "H9",
      "H1",
      "H2",
      "H4",
      "H5",
      "H10",
      "H11",
      "H12",
      "H6"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_bleomycin",
          "type": "Drug",
          "label": "Bleomycin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_busulfan",
          "type": "Drug",
          "label": "Busulfan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nitrofurantoin",
          "type": "Drug",
          "label": "Nitrofurantoin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amiodarone",
          "type": "Drug",
          "label": "Amiodarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nintedanib",
          "type": "Drug",
          "label": "Nintedanib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_pirfenidone",
          "type": "Drug",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_gabapentin",
          "type": "Drug",
          "label": "Gabapentin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_radiation_therapy",
          "type": "Drug",
          "label": "Radiation therapy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_familial_pulmonary_fibrosis",
          "type": "Disease",
          "label": "Familial pulmonary fibrosis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Bleomycin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Busulfan",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Nitrofurantoin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Amiodarone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Nintedanib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Etoposide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Gabapentin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Radiation therapy",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_bleomycin",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Bleomycin 已知副作用可导致肺纤维化"
        },
        {
          "source": "drug_busulfan",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Busulfan 可能引起肺部毒性，导致肺纤维化"
        },
        {
          "source": "drug_nitrofurantoin",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Nitrofurantoin 关联肺部并发症"
        },
        {
          "source": "drug_amiodarone",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Amiodarone 可引起肺部损害"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Methotrexate 与肺纤维化风险关联"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Cyclophosphamide 已知可导致肺部副作用"
        },
        {
          "source": "drug_nintedanib",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Nintedanib 用于特发性肺纤维化"
        },
        {
          "source": "drug_pirfenidone",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Pirfenidone 被批准用于特发性肺纤维化"
        },
        {
          "source": "drug_etoposide",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Etoposide 可能引起肺毒性"
        },
        {
          "source": "drug_doxorubicin",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Doxorubicin 与肺纤维化风险有关"
        },
        {
          "source": "drug_gabapentin",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Gabapentin 虽主要用于神经病痛，但恢复相关研究"
        },
        {
          "source": "drug_radiation_therapy",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "放疗可引起放射性肺炎"
        },
        {
          "source": "drug_nintedanib",
          "target": "H1",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Nintedanib 可能在该特定疾病中发挥正面作用"
        },
        {
          "source": "drug_pirfenidone",
          "target": "H2",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Pirfenidone 是针对特发性肺纤维化的药物"
        },
        {
          "source": "drug_amiodarone",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与肺纤维化相关的副作用"
        },
        {
          "source": "drug_methotrexate",
          "target": "H5",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Methotrexate 可能导致肺纤维化"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H7_round5",
        "key_assumptions": [
          "Nintedanib 被批准用于特发性肺纤维化",
          "相对安全性高"
        ],
        "caveats": [
          "对特定人群效果的进一步验证仍需进行"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H8",
        "candidate": {
          "id": "drug_pirfenidone",
          "name": "Pirfenidone"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H8_round5",
        "key_assumptions": [
          "Pirfenidone 被批准用于特发性肺纤维化",
          "与其他药物相比较为安全"
        ],
        "caveats": [
          "临床结果需进一步的长期观察数据"
        ],
        "confidence": "high"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Nintedanib/Pirfenidone → Familial pulmonary fibrosis",
          "reason": "两者都被用于治疗特发性肺纤维化且具有正面效果"
        }
      ],
      "remaining_gaps": [
        "关于其他药物（如 Bleomycin 和 Busulfan）在肺纤维化中的具体作用机制仍需进一步探讨"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "关注药物的特定适应症与安全性评估数据，明确支持与反对证据的来源。"
      },
      {
        "role": "Skeptic",
        "patch": "针对安全性问题提供确凿的临床证据，同时关注特定人群的反应。"
      },
      {
        "role": "Explorer",
        "patch": "积极探索新药，对特定疾病的效果进行集中研究，确保覆盖未解的机制路径。"
      }
    ],
    "heuristics": [
      {
        "when": "特发性肺纤维化",
        "then": "比较各候选药物的短期与长期疗效以及安全性"
      }
    ]
  }
}